BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8125419)

  • 1. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
    Münzel T; Kurz S; Drexler H
    Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral adaptation in chronic heart failure: therapeutic implications].
    Drexler H
    Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congestive heart failure: from cardiac muscle to skeletal muscle].
    Ferrari R; Bernocchi P; Boraso A; Visioli O
    Cardiologia; 1993 Dec; 38(12 Suppl 1):45-50. PubMed ID: 8020046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
    Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
    Guazzi M; Melzi G; Marenzi GC; Agostoni P
    Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergospirometry in the evaluation of cardiovascular drugs].
    Kleber FX; Doering W
    Z Kardiol; 1994; 83 Suppl 3():89-96. PubMed ID: 7941678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure.
    Drexler H
    Am J Cardiol; 1992 Oct; 70(10):50C-54C. PubMed ID: 1414895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of vascular endothelial gene expression by physical training in patients with chronic heart failure.
    Testa M; Ennezat PV; Vikstrom KL; Demopoulos L; Gentilucci M; Loperfido F; Fanelli R; Kitsis RN; Leinwand LA; LeJemtel TH
    Ital Heart J; 2000 Jun; 1(6):426-30. PubMed ID: 10929744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physical training of patients with high grade compromise of heart pumping function].
    Schuler G; Hambrecht R
    Z Kardiol; 1996; 85 Suppl 6():253-61. PubMed ID: 9064974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of heart failure: peripheral vascular and muscular mechanisms].
    Kiowski W
    Ther Umsch; 1993 Jun; 50(6):394-400. PubMed ID: 8351668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes in perfusion in patients with dilated cardiomyopathy.
    Kemppainen J; Stolen K; Kalliokoski KK; Salo T; Karanko H; Viljanen T; Airaksinen J; Nuutila P; Knuuti J
    J Card Fail; 2003 Aug; 9(4):286-95. PubMed ID: 13680549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of exercise testing in heart failure.
    Swedberg K; Gundersen T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S13-7. PubMed ID: 7514235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.
    Scott AC; Wensel R; Davos CH; Georgiadou P; Ceri Davies L; Coats AJ; Francis DP; Piepoli MF
    Eur Heart J; 2004 Oct; 25(20):1806-13. PubMed ID: 15474695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.